Jefferies analyst David Steinberg views Akorn (AKRX) as a "logical takeout candidate" and feels Fresenius SE (FSNUY) makes sense as a potential buyer. The analyst has long viewed Akorn as an attractive acquisition candidate given its "high margin, niche generics business and deep maturing pipeline." One could argue the company could command a 4.5-5 times revenue multiple or an implied takeover price of $36-$40 per share, Steinberg tells investors in a research, mimicking his counterpart Chris Cooper who covers Fresenius as Jefferies. Steinberg keeps a Buy rating on Akorn with a $24 price target.